Dr. Marroquin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5841 S. Maryland Ave.
Chicago, IL 60637- Is this information wrong?
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2022 - 2025
Icahn School of Medicine at Mount Sinai/Morningside/WestChief Residency, Internal Medicine, 2021 - 2022- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2018 - 2021
Johns Hopkins UniversityOncology, 2016 - 2018
Tecnologico de Monterrey Escuela de MedicinaClass of 2017
Certifications & Licensure
IL State Medical License 2022 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy.Rafael Madero-Marroquin, Emily Dworkin, Howard Weiner, Caner Saygin, Mariam T Nawas, Michael W Drazer, Adam S DuVall, Satyajit Kosuri, Michael J Thirman, Olatoyosi Ode...> ;Leukemia & Lymphoma. 2024 Mar 5
- Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors.Rafael Madero-Marroquin, Adam S DuVall, Caner Saygin, Peng Wang, Sandeep Gurbuxani, Richard A Larson, Wendy Stock, Anand Ashwin Patel> ;British Journal of Haematology. 2024 Apr 1
- 1 citationsClinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy.Timothy E O'Connor, Rafael Madero-Marroquin, Roloff, G., Shaw, R.> ;Frontiers in Oncology. 2023 Jan 1
- Join now to see all
Hospital Affiliations
University of Chicago Medical CenterChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
